Back to News

Spartan Bioscience receives Health Canada approval for first near-patient DNA test for personalized medicine.

October 30th, 2014

Spartan Bioscience today announced that Health Canada has approved the Spartan RX CYP2C19 System. It is the first near-patient DNA test for personalized medicine that has been approved in Canada.

PRWeb